SMTL ID : 3vnt.1

Crystal Structure of the Kinase domain of Human VEGFR2 with a [1,3]thiazolo[5,4-b]pyridine derivative

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.64 Å

Oligo State

monomer

Ligands

1 x 0JA: 2-chloro-3-(1-cyanocyclopropyl)-N-[5-({2-[(cyclopropylcarbonyl)amino][1,3]thiazolo[5,4-b]pyridin-5-yl}oxy)-2-fluorophenyl]benzamide(Non-covalent)

0JA.1: 25 residues within 4Å: Chain A: L.37, V.45, A.63, K.65, E.82, L.86, I.89, V.95, V.96, V.111, V.113, E.114, F.115, C.116, K.117, F.118, G.119, L.166, H.173, L.182, I.191, C.192, D.193, F.194 Ligands: EDO.2 15 PLIP interactions: 15 interactions with chain A Hydrophobic interactions: A:V.45, A:A.63, A:K.65, A:E.82, A:V.113, A:F.115, A:L.166, A:L.182, A:D.193 Hydrogen bonds: A:E.82, A:E.82, A:C.116, A:C.116, A:D.193 Halogen bonds: A:I.191

3 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.2: 4 residues within 4Å: Chain A: G.119, N.120, F.194 Ligands: 0JA.1 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:N.120, A:N.120 EDO.3: 6 residues within 4Å: Chain A: A.167, I.231, Q.232, T.299, F.300, S.301 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:F.300, A:S.301, A:S.301 EDO.4: 4 residues within 4Å: Chain A: W.243, S.247, P.275, D.276 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:D.276 Water bridges: A:D.276

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Okaniwa, M. et al., Design and synthesis of novel DFG-out RAF/vascular endothelial growth factor receptor 2 (VEGFR2) inhibitors. 1. Exploration of [5,6]-fused bicyclic scaffolds. J.Med.Chem. (2012)

Release Date

2012-04-11

Peptides

Vascular endothelial growth factor receptor 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Vascular endothelial growth factor receptor 2

Related Entries With Identical Sequence